These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28002473)

  • 21. Vaccine-induced CD8+ T cells control AIDS virus replication.
    Mudd PA; Martins MA; Ericsen AJ; Tully DC; Power KA; Bean AT; Piaskowski SM; Duan L; Seese A; Gladden AD; Weisgrau KL; Furlott JR; Kim YI; Veloso de Santana MG; Rakasz E; Capuano S; Wilson NA; Bonaldo MC; Galler R; Allison DB; Piatak M; Haase AT; Lifson JD; Allen TM; Watkins DI
    Nature; 2012 Nov; 491(7422):129-33. PubMed ID: 23023123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV.
    Almond N; Berry N; Stebbings R; Preston M; Ham C; Page M; Ferguson D; Rose N; Li B; Mee ET; Hassall M; Stahl-Hennig C; Athanasopoulos T; Papagatsias T; Herath S; Benlahrech A; Dickson G; Meiser A; Patterson S
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31413132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239.
    Vogel TU; Reynolds MR; Fuller DH; Vielhuber K; Shipley T; Fuller JT; Kunstman KJ; Sutter G; Marthas ML; Erfle V; Wolinsky SM; Wang C; Allison DB; Rud EW; Wilson N; Montefiori D; Altman JD; Watkins DI
    J Virol; 2003 Dec; 77(24):13348-60. PubMed ID: 14645590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.
    Egan MA; Charini WA; Kuroda MJ; Schmitz JE; Racz P; Tenner-Racz K; Manson K; Wyand M; Lifton MA; Nickerson CE; Fu T; Shiver JW; Letvin NL
    J Virol; 2000 Aug; 74(16):7485-95. PubMed ID: 10906202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.
    Metzner KJ; Jin X; Lee FV; Gettie A; Bauer DE; Di Mascio M; Perelson AS; Marx PA; Ho DD; Kostrikis LG; Connor RI
    J Exp Med; 2000 Jun; 191(11):1921-31. PubMed ID: 10839807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge: role of SIV-specific CD8+ T cell responses.
    Malkevitch NV; Patterson LJ; Aldrich MK; Wu Y; Venzon D; Florese RH; Kalyanaraman VS; Pal R; Lee EM; Zhao J; Cristillo A; Robert-Guroff M
    Virology; 2006 Sep; 353(1):83-98. PubMed ID: 16814356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dominant induction of vaccine antigen-specific cytotoxic T lymphocyte responses after simian immunodeficiency virus challenge.
    Takahara Y; Matsuoka S; Kuwano T; Tsukamoto T; Yamamoto H; Ishii H; Nakasone T; Takeda A; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Sakawaki H; Horiike M; Miura T; Igarashi T; Naruse TK; Kimura A; Matano T
    Biochem Biophys Res Commun; 2011 May; 408(4):615-9. PubMed ID: 21531211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of simian immunodeficiency virus (SIV) replication by CD8(+) T lymphocytes from macaques immunized with live attenuated SIV.
    Gauduin MC; Glickman RL; Means R; Johnson RP
    J Virol; 1998 Aug; 72(8):6315-24. PubMed ID: 9658070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD8+ lymphocyte antiviral activity in monkeys immunized with SIV recombinant poxvirus vaccines: potential role in vaccine efficacy.
    Leno M; Carter L; Venzon DJ; Romano J; Markham PD; Limbach K; Tartaglia J; Paoletti E; Benson J; Franchini G; Robert-Guroff M
    AIDS Res Hum Retroviruses; 1999 Mar; 15(5):461-70. PubMed ID: 10195756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective Immune Responses Elicited by Deglycosylated Live-Attenuated Simian Immunodeficiency Virus Vaccine Are Associated with IL-15 Effector Functions.
    Watanabe S; Fujino M; Saito Y; Ahmed N; Sato H; Sugimoto C; Okamura T; Hanaki K; Nakayama EE; Shioda T; Matsushima K; Ansari AA; Villinger F; Mori K
    J Immunol; 2020 Sep; 205(5):1331-1344. PubMed ID: 32747501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
    Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Live attenuated lentivirus infection elicits polyfunctional simian immunodeficiency virus Gag-specific CD8+ T cells with reduced apoptotic susceptibility in rhesus macaques that control virus replication after challenge with pathogenic SIVmac239.
    Genescà M; Rourke T; Li J; Bost K; Chohan B; McChesney MB; Miller CJ
    J Immunol; 2007 Oct; 179(7):4732-40. PubMed ID: 17878372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macaques vaccinated with live-attenuated SIV control replication of heterologous virus.
    Reynolds MR; Weiler AM; Weisgrau KL; Piaskowski SM; Furlott JR; Weinfurter JT; Kaizu M; Soma T; León EJ; MacNair C; Leaman DP; Zwick MB; Gostick E; Musani SK; Price DA; Friedrich TC; Rakasz EG; Wilson NA; McDermott AB; Boyle R; Allison DB; Burton DR; Koff WC; Watkins DI
    J Exp Med; 2008 Oct; 205(11):2537-50. PubMed ID: 18838548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Replication, immunogenicity, and protective properties of live-attenuated simian immunodeficiency viruses expressing interleukin-4 or interferon-gamma.
    Stahl-Hennig C; Gundlach BR; Dittmer U; ten Haaft P; Heeney J; Zou W; Emilie D; Sopper S; Uberla K
    Virology; 2003 Jan; 305(2):473-85. PubMed ID: 12573592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunization with a live, attenuated simian immunodeficiency virus vaccine leads to restriction of viral diversity in Rhesus macaques not protected from pathogenic challenge.
    Sodora DL; Sheridan KE; Marx PA; Connor RI
    J Virol; 1999 May; 73(5):4443-6. PubMed ID: 10196343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simian immunodeficiency virus promoter exchange results in a highly attenuated strain that protects against uncloned challenge virus.
    Blancou P; Chenciner N; Ho Tsong Fang R; Monceaux V; Cumont MC; Guétard D; Hurtrel B; Wain-Hobson S
    J Virol; 2004 Feb; 78(3):1080-92. PubMed ID: 14722263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Live attenuated SIV vaccines are not effective in a postexposure vaccination model.
    Linhart H; Gundlach BR; Sopper S; Dittmer U; Mätz-Rensing K; Kuhn EM; Müller J; Hunsmann G; Stahl-Hennig C; Uberla K
    AIDS Res Hum Retroviruses; 1997 May; 13(7):593-9. PubMed ID: 9135877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of CD8+ lymphocyte depletion on virus containment after simian immunodeficiency virus SIVmac251 challenge of live attenuated SIVmac239delta3-vaccinated rhesus macaques.
    Schmitz JE; Johnson RP; McClure HM; Manson KH; Wyand MS; Kuroda MJ; Lifton MA; Khunkhun RS; McEvers KJ; Gillis J; Piatak M; Lifson JD; Grosschupff G; Racz P; Tenner-Racz K; Rieber EP; Kuus-Reichel K; Gelman RS; Letvin NL; Montefiori DC; Ruprecht RM; Desrosiers RC; Reimann KA
    J Virol; 2005 Jul; 79(13):8131-41. PubMed ID: 15956558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine.
    Qureshi H; Ma ZM; Huang Y; Hodge G; Thomas MA; DiPasquale J; DeSilva V; Fritts L; Bett AJ; Casimiro DR; Shiver JW; Robert-Guroff M; Robertson MN; McChesney MB; Gilbert PB; Miller CJ
    J Virol; 2012 Feb; 86(4):2239-50. PubMed ID: 22156519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limited dissemination of pathogenic SIV after vaginal challenge of rhesus monkeys immunized with a live, attenuated lentivirus.
    Stone M; Ma ZM; Genescà M; Fritts L; Blozois S; McChesney MB; Miller CJ
    Virology; 2009 Sep; 392(2):260-70. PubMed ID: 19647847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.